169 related articles for article (PubMed ID: 38576821)
1. Immunoglobulin A glomerulonephropathy: A review.
El Labban M; Surani S
World J Clin Cases; 2024 Mar; 12(8):1388-1394. PubMed ID: 38576821
[TBL] [Abstract][Full Text] [Related]
2. Non-immunosuppressive treatment for IgA nephropathy.
Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of IgA Nephropathy: A Global Perspective.
Schena FP; Nistor I
Semin Nephrol; 2018 Sep; 38(5):435-442. PubMed ID: 30177015
[TBL] [Abstract][Full Text] [Related]
4. Cyclic neutropenia and concomitant IgA nephropathy: a case report.
Kapogiannis C; Zaggogianni T; Stergiou N; Kakleas K; Kapogiannis A; Gakiopoulou H; Kanaka-Gantenbein C
BMC Nephrol; 2023 May; 24(1):124. PubMed ID: 37138249
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive agents for treating IgA nephropathy.
Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade.
Chen J; Liu S; Xu H; Wang W; Xie Y; Tang W; Yuan Q; Zheng L; Lin L; Fu S; Shen J
Med Sci Monit; 2020 Aug; 26():e922839. PubMed ID: 32822333
[TBL] [Abstract][Full Text] [Related]
7. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
8. [Glomerulonephritis and vasculitis as causes of arterial hypertension].
Eicken S; Gugger M; Marti HP
Ther Umsch; 2012 May; 69(5):283-94. PubMed ID: 22547360
[TBL] [Abstract][Full Text] [Related]
9. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
Hoshino Y; Kaga T; Abe Y; Endo M; Wakai S; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
Tan M; Li W; Zou G; Zhang C; Fang J
Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
[TBL] [Abstract][Full Text] [Related]
11. Non-immunosuppressive therapies for childhood IgA nephropathy.
Shima Y; Nakanishi K; Yoshikawa N
Pediatr Nephrol; 2021 Oct; 36(10):3057-3065. PubMed ID: 33594462
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
; Jiang XY
Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
[TBL] [Abstract][Full Text] [Related]
13. Treatment of IgA nephropathy: an update.
Rosselli JL; Thacker SM; Karpinski JP; Petkewicz KA
Ann Pharmacother; 2011 Oct; 45(10):1284-96. PubMed ID: 21954446
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
Vaz de Castro PAS; Bitencourt L; Pereira BWS; Lima AQR; Hermida HS; Moreira Neto CR; Mestriner MD; Simões E Silva AC
Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
[TBL] [Abstract][Full Text] [Related]
15. The Treatment of IgA Nephropathy.
Lai KN; Leung JC; Tang SC
Kidney Dis (Basel); 2015 May; 1(1):19-26. PubMed ID: 27536661
[TBL] [Abstract][Full Text] [Related]
16. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
[TBL] [Abstract][Full Text] [Related]
17. Treatment of IgA nephropathy.
Barratt J; Feehally J
Kidney Int; 2006 Jun; 69(11):1934-8. PubMed ID: 16641928
[TBL] [Abstract][Full Text] [Related]
18. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
[TBL] [Abstract][Full Text] [Related]
19. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
20. Effect of hematuria on the kidney disease progression in IgA nephropathy patients with mild proteinuria and well-preserved renal function.
Liu Y; Chen H; Wang H; Li Z; Li H; Wang F; Jia J; Li D; Yan T
Int Immunopharmacol; 2023 Sep; 122():110635. PubMed ID: 37453157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
